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Abstract
DNA methylation patterns are reprogrammed in primordial germ cells and in preimplantation embryos by demethylation and
subsequent de novo methylation. It has been suggested that epigenetic reprogramming may be necessary for the embryonic
genome to return to a pluripotent state. We have carried out a genome-wide promoter analysis of DNA methylation in mouse
embryonic stem (ES) cells, embryonic germ (EG) cells, sperm, trophoblast stem (TS) cells, and primary embryonic fibroblasts
(pMEFs). Global clustering analysis shows that methylation patterns of ES cells, EG cells, and sperm are surprisingly similar,
suggestingthatwhile the sperm is a highlyspecializedcell type, itspromoter epigenomeis already largely reprogrammed and
resembles a pluripotent state. Comparisons between pluripotent tissues and pMEFs reveal that a number of pluripotency
related genes, including Nanog, Lefty1 and Tdgf1, as well as the nucleosome remodeller Smarcd1, are hypomethylated in stem
cells and hypermethylated in differentiated cells. Differences in promoter methylation are associated with significant
differences in transcription levels in more than 60% of genes analysed. Our comparative approach to promoter methylation
thus identifies gene candidates for the regulation of pluripotency and epigenetic reprogramming. While the sperm genome is,
overall, similarly methylated to that of ES and EG cells, there are some key exceptions, including Nanog and Lefty1, that are
highly methylated in sperm. Nanog promoter methylation is erased by active and passive demethylation after fertilisation
before expression commences in the morula. In ES cells the normally active Nanog promoter is silenced when targeted by de
novo methylation. Our study suggests that reprogramming of promoter methylation is one of the key determinants of the
epigenetic regulation of pluripotency genes. Epigenetic reprogramming in the germline prior to fertilisation and the
reprogramming of key pluripotency genes in the early embryo is thus crucial for transmission of pluripotency.
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Introduction
DNA methylation in CpG dinucleotides is the only known
epigenetic modification of DNA in vertebrates. DNA methylation
patterns are somatically heritable by virtue of the maintenance
methyltransferase, Dnmt1. DNA methylation has key roles in
epigenetic gene regulation and silencing, in particular in genomic
imprinting, X chromosome inactivation, and silencing of retro-
transposons [1–4]. To what extent, in general, methylation or
demethylation of gene promoters plays a role in transcriptional
regulation during development is still debated.
During mammalian development there are cycles of genome-
wide reprogramming of DNA methylation [5]. In mouse primordial
germ cells (PGCs) there is some demethylation at early stages of
their development (around E8.0) concomitant with loss of H3K9
dimethylation [6]. This early reprogramming is followed by specific
demethylation of differentially methylated regions (DMRs) in
imprinted genes from E10.5, as PGCs enter the gonads, until
E12.5,and bypartialdemethylationofrepetitiveelements[7–10].A
key biological purpose of demethylation during PGC development
is the erasure of imprints, so that they can be replaced at later stages
of gametogenesis with the appropriate gametic methylation patterns
in DMRs. These reprogramming events during PGC development
coincide with the re-expression of some pluripotency genes,
including Sox2 and Nanog [11], and the ability to derive pluripotent
stem cells (EG cells) into culture. Whilst it is not known if
demethylation is required for this re-expression of pluripotency
genes, other genes needed for germ cell development such as Mvh,
Dazl,a n dScp3 are demethylated and expressed at this time [12].
As gametogenesis progresses DNA methylation patterns are set
up in a sex- and sequence-specific manner. In the male germ line
this process starts prior to birth (around E15.5) for imprinted genes
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the female germline de novo methylation only commences after
birth [8,13–17]. Correct establishment of this DNA methylation
pattern in the male germ line is vital. Abnormal hypomethylation
of retrotransposons is observed in the absence of the de novo DNA
methyltransferase Dnmt3a [18,19] and of the Dnmt3-like gene,
Dnmt3L [18–21]. Additionally, mutants in Dnmt3a and Dnmt3L
have abnormal hypomethylation of paternally imprinted genes
and these cells fail to progress through meiosis, resulting in
infertility [20,21]. The acquisition of de novo methylation pre-
meiotically in the male germ line implies a need to maintain this
new pattern throughout the many mitotic divisions that the
spermatogonia undergo prior to meiosis.
A second major reprogramming of DNA methylation patterns
occurs after fertilisation in the early embryo. Many sequences in
the paternal genome such as Line1 repeats are actively demeth-
ylated in the zygote [9,22,23]. Sequences in the maternal genome
are passively demethylated during the cleavage divisions in the
preimplantation embryo [24,25], presumably due to the exclusion
of Dnmt1 from the nucleus [26]. The purpose of methylation
reprogramming in preimplantation embryos is not understood;
one possible explanation is that demethylation in the early embryo
is needed for the parental genomes to lose their epigenetic marks
so that the embryonic genome can return to totipotency [5].
Genome-wide hypomethylation at the morula stage is then
followed by lineage specific de novo methylation beginning at the
blastocyst stage [27], presumably carried out by Dnmt3a and
Dnmt3b [28]. It is possible that this de novo methylation leads to
epigenetic silencing of key promoters during early development.
Indeed some regulators of pluripotency are hypomethylated in
stem cells but become methylated upon differentiation in both
mouse and human [29–31].
In order to understand the dynamics of methylation repro-
gramming on a large scale we have carried out a comprehensive
genome-wide analysis of promoter methylation in the mouse
genome, comparing pluripotent and multipotent cell types (ES,
EG, and trophoblast stem (TS) cells) with germ cells (sperm), and
differentiated cells (primary embryonic fibroblasts, pMEFs). We
used the recently developed meDIP (methylated DNA Immuno-
Precipitation) method in combination with hybridisation to
genome-wide promoter tiling arrays (NimbleGen) for this
comparison [32–34]. Our original hypothesis was that the mature
gametic genome (here exemplified by sperm) was epigenetically
substantially different from pluripotent genomes (ES and EG cells).
We were therefore surprised to find that the sperm promoter
methylome very closely resembled that of pluripotent cells,
suggesting substantial reprogramming prior to fertilisation.
However, some key regulators of pluripotency such as Nanog were
methylated in sperm, demethylation occurred after fertilisation,
and this demethylation was necessary for their expression in stem
cells. The overall conclusion from this work is that DNA
methylation marks at key regulators of pluripotency are erased
in the early embryo, a process which is critical for early
development and for the establishment of a totipotent state.
Results
MeDIP Array Analysis of Mouse Promoters
We analysed methylation of 26,275 mouse promoters by
immunoprecipitation of sheared genomic DNA with an anti-5-
methylcytosine antibody and hybridisation to NimbleGen Mouse
oligonucleotide promoter tiling arrays (2005-03-31_MM5). Geno-
mic DNA was extracted from biological triplicates each of E11.5
and E12.5 EG cells, ES cells, TS cells, sperm, and primary mouse
embryonic fibroblasts from E12.5 embryos (pMEFs), and was
immunoprecipitated. The quality of the immunoprecipitation was
determined by analysing enrichment of two genes with known
methylation patterns (data not shown).
Examining the overall distribution of signals on the arrays we
found an increase in average signal intensity between 0–5% CpG
content, followed by a decrease in signal for regions between 5–9%
CpG content and a flat line for regions above 9% CpG content
(Figure 1A). This distribution reflects the generally hypomethy-
lated state of CpG-rich promoters and CpG islands (above 9%
CpG content), whilst we infer that relatively CpG-poor promoters
can become methylated in normal tissues. The pattern observed
for mouse promoters is thus similar to that recently reported for
human promoters, using the same assay [34].
It has been shown that genes with very low CpG content
promoters tend to be constitutively highly methylated [34,35],
while genes with high CpG content promoters often contain CpG
islands which generally remain unmethylated. In agreement with
this, we found that high CpG content promoters are mostly
unmethylated (Figure 1B). In addition, we notice that most of the
microarray signals from the high CpG content promoters failed to
pass our significance test (see Experimental Procedures for details),
suggesting a potential technical difficulty in measuring the
methylation signals in the high CpG content regions. Therefore,
we limited our subsequent analyses to a CpG content between 2
and 9%, thus excluding highly methylated CpG poor promoters
(,2%) and those unmethylated promoters which contain CpG
islands (.9%) (Table S1). This category of promoters corresponds
to that termed ‘intermediate CpG promoter (ICP) class’ [34], in
which most dynamic changes in methylation appear to occur in
humans [34].
Clustering Analysis Reveals Global Reprogramming of the
Sperm Genome
ES and EG cells are pluripotent and derived from within the
embryonic lineage [36–38], while TS cells are more restricted in
Author Summary
Large scale epigenetic reprogramming occurs in mamma-
lian germ cells and the early embryo. The biological
purpose of this reprogramming is largely unknown,
although it has been suggested that it may be required
for the embryonic genome to return to a pluripotent state.
We carried out a genome-wide screen of promoter
methylation in the mouse, comparing germ cells with
pluripotent cells, multipotent cells, and more differentiat-
ed cell types. We find that promoter methylation is an
epigenetic signature of developmental potency. Genes
linked to pluripotency are generally hypomethylated in
stem cells and hypermethylated (and silenced) in more
differentiated cell types, and our genome-wide screen
provides new candidates for the regulation of pluripoten-
cy. Importantly, germ cells resemble pluripotent cell types
in that most promoters have been reprogrammed.
However, a small group of key pluripotency regulators
(including Nanog), are methylated in mature germ cells,
presumably in order to suppress pluripotency at critical
stages of germ cell differentiation. Indeed, methylation
in these genes becomes reprogrammed after fertilisation
so that the embryo can regain totipotency. This work,
therefore, shows for the first time that epigenetic
reprogramming is crucial for maintaining the pluripotency
of germ and embryonic stem cells.
Epigenetic Reprogramming of Pluripotency Genes
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[39], and pMEFs are a committed mesodermal cell type. We were
interested in comparing global methylation patterns of promoters
between these cell types. To make these comparisons the ratios
from the meDIP arrays were used to generate a correlation value
between each pair of tissues (Figure 2A). This clearly showed that
the global promoter methylation patterns of ES cells, EG cells and
sperm correlate well with each other, as do those in pMEFs and
TS cells. However, methylation patterns between these two groups
(ES cells, EG cells and sperm versus pMEFs and TS cells) differed
substantially and significantly (p,0.0001). This analysis also
showed that the promoter methylation profile of TS cells is less
different to that of the pluripotent cells (ES and EG cells) and
sperm than the pMEF promoter methylation is, even though they
are still significantly different (p,0.01 and p,0.0001, respective-
ly). This may reflect the diverse differentiation potentials between
TS cells and pMEFs. Since the potency of TS cells is restricted to
the extraembryonic trophoblast lineage, it suggests that its
differentiation potential is more constrained by DNA methylation
than that of ES or EG cells, but somewhat less constrained than
that of pMEFs. On the other hand, the tight correlation of EG
with ES cells is perhaps expected given that both cell types are
pluripotent, and should only differ in the methylation of the small
number of imprinted genes [40] and potentially of autosomal germ
line-restricted genes [35,41,42]. The correlation of EG and ES
cells with sperm was surprising, but suggests that, as far as
promoter methylation is concerned, sperm is very comparable to
pluripotent cell types. Indeed, most promoters that were found
hypomethylated in ES cells but hypermethylated in pMEFs were
also hypomethylated in sperm, and this general pattern was
confirmed by sequence-specific methylation analysis (see below,
Figure 3A). We conclude that overall, promoters in sperm are
already epigenetically reprogrammed and resemble those in
pluripotent cell types.
This global analysis suggests that promoter methylation is an
epigenetic signature of developmental potency given that the most
pronounced changes occurred between ES/EG cells and pMEFs,
and between ES/EG and TS cells, respectively. The global meDIP
analysis provided mean signal intensity values that required
correction to identify the baseline between methylated and
unmethylated sequences. As an alternative we pursued a
comparative approach and Gene Ontology (GO) analysis was
used to identify categories within which genes differed significantly
in promoter methylation patterns between ES cells and pMEFs or
ES and TS cells (Figure 2B, C and Table 1). Interestingly, the
majority of differences occurred in the same direction, with
promoters being hypomethylated in ES cells, and hypermethylated
in pMEFs or TS cells, respectively. Three GO categories (nucleus,
regulation of transcription, zinc ion binding) were shared between
the two comparisons between cell types, indicating that most genes
that are hypomethylated in pluripotent cells are likely to act in the
nucleus and be involved in transcriptional regulation. GO
categories that differ between the groups may indicate molecular
pathways that are more prevalent in embryonic (ubiquitin cycle,
posttranslational modifications) or extraembryonic (RNA process-
ing) lineage diversification, respectively.
Candidate Regulators of Pluripotency Identified by Their
Epigenetic Signatures
Having found that specific categories of genes differed in their
promoter methylation between ES cells and pMEFs, and ES and
TS cells, we were interested in examining individual genes in these
categories in more detail. We used a more stringent algorithm than
for the GO analysis in selecting potential pluripotency genes by
using a sliding window approach to account for consistency of
methylation signals within a number of probes in the promoter
region. In addition, we applied a minimum threshold for the
pMEFs and TS signal (Log2 .1.6 and .1.2, respectively) and a
maximum threshold for the ES signal (Log2 ,0.9) in order to
select genes with the most pronounced differences in promoter
methylation between ES cells versus pMEFs (Table S2) and ES
cells versus TS cells (Table S3). The promoter regions of the genes
predicted to be differentially methylated were subsequently
validated using Sequenom MassArray methylation analysis, by
which the methylated or unmethylated DNA fragments were
measured quantitatively by mass spectrometry analysis. Our
results showed that 88% (22/25) of candidates are validated for
the ES cell versus pMEFs comparison (Figure 3A) and 100% (9/9)
for the ES cell versus TS cell comparison (Figure 4A). We
therefore conclude that our MeDIP experiment provides a robust
predictor of differential methylation states between the cell types.
Strikingly, whilst 69 genes were predicted by our algorithm to
be hypomethylated in ES cells and hypermethylated in pMEFs
(Table S2), there were no genes that met the reverse criteria. Oct4
was excluded from the analysis as it did not pass the significance
filter, even though upon individual analysis some probes in its
promoter were shown to be highly methylated in pMEFs. Using
Sequenom MassArray technology, we were able to measure DNA
methylation levels quantitatively which confirmed that these gene
promoters were hypomethylated in ES cells and hypermethylated
in pMEFs (Figure 3A). Similarly, examining the top ranking 70
genes from the ES cells versus TS cells comparison, we found that
the great majority of genes were hypomethylated in ES cells and
methylated in TS cells (67 genes) in comparison to the reverse
pattern (3 genes) (Table S3). Figure 4A shows the genes from this
list whose methylation patterns were validated by Sequenom
MassArray. Of the genes shown in our study to be hypomethylated
and expressed (see below) in ES cells and hypermethylated and
repressed in pMEFs, indeed several are known pluripotency
regulators and early patterning genes, including Nanog, Tdgf1,
Lefty1, Rex1 (Zfp42), and chromatin regulators such as Smarcd1.
The uncharacterised genes from the comparison are therefore
excellent candidates for regulators of pluripotency.
We next examined the correlation between hypermethylation of
promoters and gene silencing by quantitative RT PCR of top
candidates from the ES cell versus pMEFs and ES cell versus TS
cell lists (Figure 3B and 4B). A substantial proportion of the
differentially methylated genes showed more than 3-fold increased
expression in ES cells compared with pMEFs (17 of 28 genes,
61%) or TS cells (7 of 16 genes, 44%). In contrast very few genes
showed increased expression in the hypermethylated cell type (1 of
28 genes and 0 of 16 genes, respectively). Interestingly, of the
approximately 70 genes predicted to differ in promoter methyl-
Figure 1. Global relationship between meDIP signal and CpG content. (A) Scatter plot of meDIP methylation signal (Log2 ratio) in all
promoters with varying CpG content (example shown is from an ES cell sample and is representative of the pattern observed in all cell types
analysed). There is an initial rise in signal up to 5% CpG content, followed by a sudden drop in signal for promoters with above 5% CpG content. (B)
Promoters with more than 9% CpG content were mostly unmethylated in different cell types, as revealed by Sequenom analysis. Four examples are
shown whose methylation was compared between ES and TS cells.
doi:10.1371/journal.pgen.1000116.g001
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and TS cells, only 14 are common to both lists (Figure 5A, Table
S4). This indicates that the differentiation pathways that are
epigenetically inactivated in embryonic and extraembryonic
lineages differ substantially from each other. We also analysed
the developmental expression profiles of the Sequenom-validated
genes on the ES cell versus pMEFs list using GNF SymAtlas.
Expression data were available for 33 of the genes which are
hypomethylated in ES cells and hypermethylated in pMEFs.
Interestingly, the most common expression profile is one of
predominant expression in either blastocysts, or in oocytes and
fertilised eggs, or both (Table 2).
Genes that are hypomethylated in ES cells and hypermethylated
in pMEFs or TS cells are potentially regulators of pluripotency. It
is known that Oct4 and Nanog are key transcription factors which
regulate pluripotency and self-renewal of ES cells; we therefore
analysed our meDIP data for those genes found in a recent
genome-wide study to be bound in ES cells by Oct4 or Nanog
[43]. Significantly, genes bound by Oct4 or Nanog in ES cells
become methylated in pMEFs and in TS cells (Figure 5B). Since
Oct4 and Nanog are not expressed in either pMEFs or TS cells,
this strong correlation suggests that DNA methylation may control
the repression of the Oct4/Nanog regulatory network when
pluripotency is lost.
Polycomb group (PcG) proteins are required for the mainte-
nance of ES cell pluripotency and developmental plasticity [44–
47]. To determine whether PcG complex occupancy is associated
with DNA methylation, we compared our meDIP results to a
global study of PcG-targeted genes in mouse ES cells [45]
(Figure 5B). Genes occupied by key PRC1 and PRC2 proteins in
ES cells were not found to be hypermethylated in pMEFs. This
suggests that most of the genes targeted by PcG are silenced during
embryonic development independently of DNA methylation.
However, we did find a significant enrichment of genes that are
hypermethylated in TS cells amongst genes occupied by PRC2 but
not PRC1 complex in ES cells (Figure 5B).
To reveal any correlation between histone modifications and
DNA methylation, genes with specific histone modifications in ES
cells [48] were compared with our meDIP data (Figure 5B). Genes
hypomethylated in ES cells (compared to pMEFs and TS cells)
were found to be significantly enriched within those genes marked
by trimethylated lysine 4 of histone H3 (H3K4me3). We found no
significant correlations between either the repressive histone mark
(H3K27me3), or the bivalent mark (H3K4me3 and H3K27me3)
compared to differential DNA methylation.
Key Pluripotency Gene Promoters Are Methylated in
Sperm and Need to be Reprogrammed for Embryos to
Attain Pluripotency
Our analysis has shown that the majority of promoters that are
hypomethylated in ES and EG cells are also hypomethylated in
sperm. However, there are a small number of exceptions to this
rule which are interesting and important. The promoters of Nanog,
Lefty1, Brd1, Slc5a4a, and Slc39a4 were highly methylated in sperm
while being hypomethylated in ES and EG cells (Figure 3A). In
addition Oct4 and Sox2 are also found to be methylated in
regulatory regions in sperm, albeit outside of the immediate
promoter region [42]. This observation raises the question
whether the promoters of these genes are reprogrammed by
demethylation after fertilisation. Indeed, we confirmed by
bisulphite sequencing that whilst the promoter of Nanog was
completely methylated in sperm, it was demethylated in the zygote
to an overall extent that indicates active demethylation (Figure 6A).
Methylation was also analysed at later stages and the results
suggest that passive demethylation occurs during further cleavage
divisions until the promoter is virtually unmethylated at blastocyst
stage (Figure 6A, B). This indicates that reprogramming of the
Nanog promoter occurs by both active and passive demethylation
during preimplantation development, explaining the unmethy-
lated status of the promoter in ES cells
We next determined if methylation of the Nanog promoter
inhibited its expression in pluripotent tissues. Transfection of ES
cells with Nanog-GFP and UAS-Nanog-GFP promoter reporter
constructs in combination with Gal4-Dnmt3a de novo methyltrans-
ferase expression vectors [49] was used to target methylation of the
UAS-Nanog promoter (Figure 7). A control plasmid expressing a red
fluorescent protein (pDsRed-C1 RFP) was used to normalize the
efficiency between different co-transfections. Transfection of a
wild-type Nanog-GFP reporter plasmid (LR-Nanog-GFP) with wild-
type Gal4-Dnmt3a expression vector into mouse ES cells resulted in
expression of GFP as expected (95% of RFP expressing cells
expressed GFP), while co-transfection with a reporter plasmid
containing UAS sequences (UAS-Nanog-GFP) led to Gal4-Dnmt3a
targeted DNA methylation (41%, Figure 7) accompanied by
silencing of the UAS-Nanog-GFP construct (14% of RFP expressing
cells expressed GFP). This is in contrast to the co-transfection with
a catalytic mutant of Gal4-Dnmt3a, where the Nanog promoter was
neither methylated nor silenced (80% of RFP expressing cells
expressed GFP). We conclude that reprogramming by demethyl-
ation is necessary for proper expression of Nanog in ES cells, and
hence for pluripotency of the early embryo.
Discussion
Using the meDIP technique by which methylated DNA is
precipitated and hybridised onto oligonucleotide arrays [34] we
have carried out the first genome-wide analysis of DNA
methylation of promoters in the mouse genome in which germ
cells (sperm) and pluripotent cell types (ES and EG cells) were
compared with more restricted multipotent stem cells (TS cells),
and more differentiated cells (pMEFs). Algorithms were developed
to assess differences in promoter methylation between the different
cell types, and validated using a bisulphite treated DNA and mass
spectrometry based analysis (Sequenom MassArray). We find that
the meDIP method combined with array hybridisation and
stringent bioinformatics evaluation is a robust method for
genome-wide evaluation of DNA methylation patterns.
Global comparisons between different cell types strongly suggest
that promoter methylation is an epigenetic signature of develop-
mental potency. Our study thus provides three key insights into the
epigenetic regulation of pluripotency. Firstly, we find that a
considerable number of gene promoters become methylated during
stem cell differentiation. Secondly, our global clustering analysis
shows that methylation patterns of promoters in ES cells, EG cells
Figure 2. Global comparisons of promoter methylation patterns between cell types. (A) Pairwise correlation comparisons were made
between all cell types to establish the similarity of promoter methylation. R-values were compared for significant correlation both within and
between groups, and are represented by a colour-coded scale (green is highly correlated). (B) Gene Ontology analysis for genes which are
hypermethylated in pMEFs and hypomethylated in ES cells. GO terms with a significant enrichment (p,0.01) are shown. (C) Gene Ontology analysis
for genes which are hypermethylated in TS cells and hypomethylated in ES cells. GO terms with a significant enrichment (p,0.01) are shown.
doi:10.1371/journal.pgen.1000116.g002
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is a highly specialized cell type, its promoter epigenome is already
largely reprogrammed, resembling a pluripotent state. Thirdly, we
foundthatwhilethespermgenomeisoverallsimilarlymethylatedto
that of ES and EG cells, there are some key exceptions for which
reprogramming in the early embryo is necessary.
Comparing ES cells and pMEFs, the greatest differences in
methylation involve 69 gene promoters predicted to be hypo-
methylated in ES cells, and methylated in pMEFs. These genes are
also generally predicted to be hypomethylated in EG cells by our
meDIP analysis. The same holds true of the comparison between
ES and TS cells; 67 genes are predicted to be hypomethylated in
ES and hypermethylated in TS cells, but only 3 genes show the
reverse pattern. A recent study, which compared promoter
methylation in wild-type ES cells with those deficient in DNA
methylation, identified a small number of genes whose promoters
are methylated in ES cells [35]. Our study design, comparing
different cell types, would not identify genes methylated in ES cells
if they were not differentially methylated in other cell types.
Hence, we find that there is a general tendency for a subset of gene
promoters to become methylated in more differentiated cell types
and in a lineage-specific fashion, consistent with a number of other
studies which examined individual gene candidates [29–31]. Our
study focussed on promoters with a CpG content between 2 and
9%, the so called ‘intermediate CpG promoter (ICP) class’ [34], in
which most dynamic changes in methylation appear to occur at
least in humans [34].
Gene expression analysis demonstrated that up to 61% of genes
have promoter methylation associated with their relative gene
silencing, whilst the rest of validated genes with differences in
promoter methylation show little correlation in gene expression
between cell types. Thus, while promoter methylation appears to
be a major epigenetic determinant of gene expression, other
epigenetic marking systems also have important roles to play
[21,34]. For example, a recently published promoter methylation
study in ES cells suggests that demethylation is necessary but not
sufficient for gene activation [35]. Furthermore, our comparisons
of the meDIP data to whole genome histone modification mapping
and PcG-binding studies [48] support the idea that gene repression
mediated by DNA methylation or by repressive histone modifi-
cations (e.g. H3K27me3) or PcG proteins is mechanistically
unconnected. The only exception to this pattern was that genes
bound by polycomb complex proteins (such as Eed and Suz12) in
ES cells tend to become more methylated in TS cells, suggesting
that a proposed link between polycomb silencing and DNA
methylation may be restricted to the extraembryonic tissues [50].
Interestingly, Nanog and Oct4 target genes were relatively
hypomethylated in ES cells, and became hypermethylated during
cell lineage commitment. This suggests that Nanog/Oct4 binding
together with DNA hypomethylation is part of the pluripotency
network to maintain an undifferentiated cell state. This class of
genes was also broadly marked by H3K4me3 in ES cells,
suggesting that their promoters are actively protected from de novo
methylation [51] in pluripotent cell types, while this protection is
lost during lineage commitment and differentiation.
Our screen established that transcription factors represents one
of the main groups of genes being hypomethylated in ES cells,
which was also observed in another recent promoter methylation
study [35]. This finding is consistent with the fact that a number of
transcription factors are crucial for the establishment and
maintenance of the pluripotent state [52,53], and hence our
analysis may have identified additional key regulators in this
network. More unexpectedly, genes belonging to the ubiquitin
cycle and posttranslational protein modifications were enriched in
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Epigenetic Reprogramming of Pluripotency Genes
PLoS Genetics | www.plosgenetics.org 7 June 2008 | Volume 4 | Issue 6 | e1000116Figure 3. Promoter methylation and gene expression compared between ES cells and pMEFs. (A) Promoter methylation patterns in ES
cells (red bars), early passage pMEFs (pMEFs-P1, light blue bars), late passage pMEFs (pMEFs-P5, dark blue bars) and sperm (yellow bars). Candidate
promoter regions were identified by the meDIP screen and validated by Sequenom analysis. The number of differentially methylated CpGs analysed
for each gene are given in brackets. (B) Gene expression differences between ES cells and pMEFs (P1) as determined by quantitative RT-PCR analysis.
The x-axis gives the log-fold expression difference between the cell types (i.e., log [ES/pMEF]). Three reference genes (Dynein, Rsp23 and Hdac10-11)
were used for normalization between cell types.
doi:10.1371/journal.pgen.1000116.g003
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PLoS Genetics | www.plosgenetics.org 8 June 2008 | Volume 4 | Issue 6 | e1000116Figure 4. Promoter methylation and gene expression compared between ES and TS cells. (A) Promoter methylation patterns in ES cells
(red bars) and TS cells (green bars). Candidate promoter regions were identified by the meDIP screen and validated by Sequenom analysis. The
number of differentially methylated CpGs analysed for each gene are given in brackets. (B) Gene expression differences between ES and TS cells as
determined by quantitative RT-PCR analysis. The x-axis gives the log-fold expression difference between the cell types (i.e., log [ES/TS]). Three
reference genes (Dynein, Pmm1 and Sdha) were used for normalization.
doi:10.1371/journal.pgen.1000116.g004
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PLoS Genetics | www.plosgenetics.org 9 June 2008 | Volume 4 | Issue 6 | e1000116the ES cells versus pMEFs comparison. The ubiquitin cycle is a
part of the process of posttranslational protein modification and
includes both deubiquitination and ubiquitination of proteins,
including histones [54]. Of note is the presence of Rnf2 (Ring1B), a
member of the polycomb repressive complex 1 (PRC1), which
mediates the monoubiquitination of histone H2A lysine 119 [55]
and has recently been shown to have an important role in
repressing developmental control genes in ES cells [56]. Epigenetic
regulation through histone ubiquitination may be an, as yet,
unexplored facet of pluripotent cell types. Differences in
expression and activity of genes related to the ubiquitin cycle
may also be related to a different rate of protein degradation in ES
cells and pMEFs. The pluripotent nature of ES cells involves their
ability to rapidly respond to stimuli such as differentiation signals.
Therefore, they would be predicted to have a higher rate of
protein turnover than differentiated cells, and indeed such a
Figure 5. Global comparisons between promoter methylation and chromatin signatures. (A) Venn diagram showing the overlapping
genes between ES cell versus pMEFs (blue) and ES cell versus TS cell (yellow) datasets. 14 genes were found in common and show hypermethylation
in lineage committed and differentiated cell types. (B) Comparison of differentially methylated genes in the ES cell versus pMEFs or ES cell versus TS
cell dataset with ChIP datasets of Nanog/Oct4- and PcG-binding sites [43,45], and histone H3K4/H3K27 methylation [48] in ES cells. Correlations with
p-values of ,0.05 are regarded as significant. Genes analyzed were all hypomethylated in ES cells and hypermethylated in pMEFs or TS cells.
doi:10.1371/journal.pgen.1000116.g005
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PLoS Genetics | www.plosgenetics.org 10 June 2008 | Volume 4 | Issue 6 | e1000116correlation has been found in the myogenic differentiation
pathway [57].
Our meDIP data show that genes with the most pronounced
methylation differences between ES cells and pMEFs have a
preference for expression in early development. This suggests that
early transcriptional competence is retained as hypomethylation
within the cells of the ICM, and thus ES cells where expression
may be reduced by other mechanisms, and subsequently
permanently repressed by hypermethylation in differentiated cells.
Through this comparison, we identified genes that include
pluripotency factors and early patterning genes such as Nanog
[58], Tdgf1 [59], and Lefty1 [60], genes involved in RNA transport
with a function in germ cells such as Akap1 [61,62], the regulator of
apoptosis, Bcl2l10 [63], and the tumour suppressor gene Mia2
[64]. Of particular interest are the nucleosome remodelling factor
Smarcd1 [65], and the putative bromodomain gene Brd1 [66].
Additionally, when this comparison was evaluated against the ES
versus TS cell comparison, 14 genes were found to be overlapping
on the lists (Table S4). Presumably this comparison is also enriched
for genes with functions in the germline, early embryogenesis, and
the regulation of pluripotency. A role in these processes can
therefore also be envisaged for the genes that came out of these
comparisons whose function is yet to be determined.
We find that promoter methylation in sperm is strikingly similar
to that in ES and EG cells. This means that the sperm genome, on
the whole, has not acquired promoter methylation that would
need to be erased after fertilisation to enable zygotic gene
expression from the paternal genome. Thus, while the sperm itself
is a highly differentiated cell type with a specialised function, its
promoter methylome resembles that of other cell types of the
pluripotency-germline cycle. Importantly this suggests that pro-
moters in sperm, on a genome-wide scale, do not need to undergo
extensive reprogramming by demethylation at fertilisation. This is
in agreement with recently published work analysing differentially
methylated regions specific to the testis [21], which tended not to
be found in typical promoter regions. Gene promoters may be
protected during spermatogenesis from substantial de novo
methylation events which occur in other sequences. Large scale
demethylation of the paternal genome upon fertilisation is thus
likely to occur preferentially in transposons, and perhaps in inter
and intragenic regions. Indeed, the Line1 family transposons (with
about 100,000 members in the mouse genome) are massively
demethylated upon fertilisation [9].
Whilst the global methylation of the sperm genome, as analysed
by meDIP, closely resembles that of the pluripotent cell types, ES
and EG cells, there are some notable and important exceptions to
this rule. The promoters of genes such as Nanog, Lefty1, and Brd1
are highly methylated in sperm; this is also observed for Oct4, Fgf4,
Fbx15, and Sox2 (albeit outside of the promoter) in other studies
[42,67]. These genes alone or in combination are key regulators of
the pluripotent state. Hence, they may not only have to be
permanently silenced in somatic cells, but also during the later
stages of spermatogenesis when pluripotency is lost. This
regulation might resolve a conflict within the germ line between
transmitting totipotency to the next generation, whilst preventing
the formation of teratomas. Reprogramming of these key genes by
demethylation after fertilisation would be required to achieve
pluripotency of early embryos. Indeed our experiments show that
the promoter of Nanog is rapidly demethylated after fertilisation by
both active and passive demethylation and is virtually unmethy-
lated in the morula when its expression commences. This
demethylation is necessary for expression as shown by targeting
de novo methylation to the Nanog promoter in ES cells, which
resulted in significant transcriptional silencing. Suppression of
Nanog promoter activity by in vitro methylation has also been shown
in a reporter assay in both ES and TS cells [68]. We have not
examined methylation in preimplantation embryos of the other
genes we found methylated in sperm; however, we suggest that
they become demethylated early after fertilisation since they lack
methylation in ES cells. Erasure of DNA methylation at specific
key loci in the early embryo is therefore one of the epigenetic
reprogramming events necessary for the establishment of the
pluripotent state.
It is interesting to ask if these regulators of pluripotency are not
only epigenetically silenced in somatic cells and definitive
gametogenesis, but also during the allocation of PGCs in the
early postimplantation embryo. For example, Nanog expression is
silenced in early PGCs (E7.25) but is re-expressed from E7.75,
coincident with the ability of deriving pluripotent EG cells into
culture [11]. It is not known whether this cycle of silencing and re-
expression also involves DNA methylation, but the timing of re-
expression coincides with some major epigenetic erasure events in
the PGCs, including DNA demethylation [6]. We therefore
speculate that there might be another cycle of de novo methylation
and demethylation in early PGCs, and that this may be required
for pluripotency of EG cells.
We conclude that most promoters in the mouse genome remain
unmethylated during the germline-pluripotency life-cycle. This
guards the germline against acquisition of metastable epi-alleles
and their transmission to future generations [69]. A small number
of genes which regulate pluripotency undergo cycles of de novo
methylation and demethylation in the germline and the early
Table 2. SymAtlas expression patterns of differentially
methylated genes between ES cells and pMEFs.
Gene
Oocyte and
Fertilised egg Blastocyst
.3 .10 .3 .10
Tcl1 N
Akap1 NN
Smn1 N
Stau1 N
ENSMUSG00000032460 NN
Tdgf1 N
Bcl2l10 N
Arhgap8 N
Narg2 N
Plet1 N
Nanog N
Brd1 NN
Slc39a4 N
Tdh N
Zfp42 N
Patterns of expression in blastocysts, oocytes and/or fertilised eggs of genes
with differential methylation between ES cells and pMEFs (Figure 3A) as
retrieved from SymAtlas [76]. Values of expression indicated are in multiples of
the median expression. Where no mark is shown expression for that gene in cell
type was ,3 fold over the median expression. Patterns of expression relative to
the median within the oocyte and fertilised egg were for these genes the same
so were combined. Genes are selected from Figure 3A; only those with
expression enriched in blastocysts, oocytes and/or fertilised eggs are shown in
the table.
doi:10.1371/journal.pgen.1000116.t002
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PLoS Genetics | www.plosgenetics.org 11 June 2008 | Volume 4 | Issue 6 | e1000116Figure 6. Epigenetic reprogramming of the Nanog promoter during preimplantation development. (A) Methylation patterns of the
Nanog promoter in gametes and in early fertilised embryos were determined by bisulphite sequencing analysis. The Nanog promoter is highly
methylated in sperm but hypomethylated in fertilised embryos. CpG dinucleotides are represented as open circles (unmethylated) or closed circles
Epigenetic Reprogramming of Pluripotency Genes
PLoS Genetics | www.plosgenetics.org 12 June 2008 | Volume 4 | Issue 6 | e1000116embryo, presumably to enable loss and re-establishment of
pluripotency in a cyclical fashion [3]. Demethylation of the
promoters of these genes is thus critical for the pluripotent part of
the germline cycle, while re-methylation is crucial for the
differentiation part of this cycle. Although it has been reported
that a pluripotent state can be induced in differentiated cells by
forced expression of a small number of key transcription factors,
the efficiency of reprogramming is low and requires a long
selection process [70–72]. Our genome-wide methylation study
might thus help to identify additional factors as well as targets with
a role in reprogramming and to improve the efficiency of the
process.
Materials and Methods
Cell Lines and Other Biological Samples
ES cells (129/Sv6129/Sv-CP) F1 were cultured on a c-
irradiated pMEF feeder cell layer with ES medium (500 ml
knockout DMEM, 90 ml knockout serum replacement (Hyclone),
6 ml 100x non-essential amino acids, 6 ml 100x pen/strep, 6 ml
100x glutamine, 4.6 ml b-mercaptoethanol, 1000 units/ml ES-
GRO (Chemicon). ES cell cultures were incubated at 37uC, 5%
CO2. Primary mouse embryonic fibroblasts (pMEFs) were isolated
from embryos at E13.5–14.5 (C57BL6/CBA) R x C57Bl6= and
cultured in fibroblast media (500 ml knockout DMEM, 50 ml
foetal bovine serum (FBS), 5 ml 100x pen/strep, 5 ml 100x
glutamine, 3.5 ml b-mercaptoethanol; all the reagents are from
GibcoBRL, Life Technologies). Embryonic germs (EG) cells were
a gift from A.Surani and were derived from PGCs from male
fetuses (MF1 X Rosa) at E11.5 [73] and E12.5 [74]. TS (GFP-
transgenic 129/SV and ICR) cells were grown on standard tissue
culture dishes without feeder cells and gelatin coating [39] and
cultured in TS complete medium with FGF4 (7 ml feeder-
conditioned medium, 3 ml TS basic medium, 10 ml 1000x FGF4
stock (Sigma), 10 ml 1000x heparin stock (Sigma)) in a standard
tissue culture incubator (37uC , 5% CO2). TS basic medium was
prepared as follows: 500 ml RPMI 1640, 50 mg/ml pen/strep,
130 ml FBS, 6.5 ml 100 mM sodium pyruvate (Gibco), 1.3 ml
50mM b-mercaptoethanol, 6.5 ml 200 mM L-Glutamine. Mature
sperm was collected from the caudal epididymis and vas deferens
of C57BL6/CBA mice.
Genomic DNA Extraction
Genomic DNA was isolated according to a standard protocol
[75] from cultured R1 ES cells, pMEFs, sperm, TS cells, E11.5
EG cells and E12.5 EG cells. Isolated genomic DNA was purified
by phenol chloroform extraction followed by ethanol precipitation,
and subsequently dissolved in water overnight. The DNA
(methylated). The percentage of CpG methylation is indicated in brackets. (B) Summary of Nanog promoter methylation during preimplantation
mouse development. The level of methylation at the Nanog promoter is given as a percentage. Methylation levels are given for the gametes and at
the preimplantation stages indicating that the Nanog promoter undergoes both active and passive demethylation after fertilisation.
doi:10.1371/journal.pgen.1000116.g006
Figure 7. Targeted DNA methylation of the Nanog promoter in ES cells silences gene expression. A Nanog-GFP reporter plasmid with or
without UAS targeting sequences was transfected into mouse ES cells together with a Gal4-Dnmt3a (wild-type or catalytic mutant) in addition to a
pDsRed-C1 RFP construct as a transfection efficiency control. The number of GFP expressing cells (green bars), RFP expressing cells (red bars), and
overlap between GFP and RFP expressing cells (yellow) was determined. Top row: transfection of Nanog-GFP without the UAS sequence together
with Gal4-Dnmt3a results in high level (95.9%) GFP expression and 0% DNA methylation of the Nanog promoter (red box). Middle row: transfection of
UAS-Nanog-GFP together with Gal4-Dnmt3a results in low level (14.5%) GFP expression and 40.9% promoter methylation. Bottom row: transfection
of UAS-Nanog-GFP together with the catalytic mutant of Gal4-Dnmt3a results in high level (80.3%) GFP expression and 2.9% promoter methylation.
Three independent transient transfection experiments were performed. P values (* indicates p,0.001) were calculated by Student’s t-Test. The red
box highlights the Nanog promoter region.
doi:10.1371/journal.pgen.1000116.g007
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PLoS Genetics | www.plosgenetics.org 13 June 2008 | Volume 4 | Issue 6 | e1000116concentration and quality were determined by measuring the
absorbance at 260 nm and 280 nm in a spectrophotometer
(Ultrospec 3100 pro, Amersham Bioscience).
Methylated DNA Immunoprecipitation (meDIP) Assay
Genomic DNA from three biological replicates of each sample
was prepared as described above. Before sonication, 20 mgo f
RNase were added to 60 mg of DNA in a total volume of 700 mlt o
digest RNA. Genomic DNA was incubated on ice and sonicated
with 20% amplitude, 4 pulses with 10 s sonication and 30 s pause.
35 ml of sonicated DNA were run in 1% agarose gels to check the
size of DNA fragments was in the range of 300 to 1000 bp.
Sonicated DNA of the correct size was subsequently recovered by
ethanol precipitation.
MeDIP was performed as described previously [33]. Briefly,
4 mg restriction enzyme digested (for subsequent PCR analysis) or
100 mg of sonicated (for genome-wide promoter array analysis)
DNA was denatured for 10 min at 95uC. The denatured DNA
fragments were immunoprecipitated using a monoclonal antibody
against 5-methylcytidine (5meC) (Eurogentec) for 2 h at 4uC with
500 ml IP buffer (10mM sodium phosphate (pH 7.0), 140 mM
NaCl, 0.05% Triton X-100). Subsequently the mixture was
incubated with 30 ml of Dynabeads coated with M-280 sheep
anti-mouse IgG antibody (Dynal Biotech) for 2 h at 4uC and
washed three times with 700 ml of IP buffer. After recovering the
pull-down methylated DNA by proteinase K digestion for 3 h at
50uC, the methylated DNA was purified by phenol-chloroform
extraction followed by ethanol precipitation. The pellet was
dissolved in nuclease free water (Ambion).
NimbleGen Array Hybridisation
Genomic profiling was done by NimbleGen Systems. Arrays are
composed of 1.5 kb of promoter regions for a minimal set of
26,275 mouse genes containing tiling 50-mers with 100 bp spacing
(NimbleGen Systems, Inc.). Three successive early passages of R1
ES, E11.5 EG, E12.5 EG, TS cells, pMEFs, and sperm from three
independent male mice older than 9 weeks were used as
independent biological replicates. Six rounds of MeDIP were
performed for every sample in order to obtain sufficient amounts
of immunoprecipitated (methylated) DNA fragments for hybrid-
ization. We provided 3 mg of sonicated DNA as input and 4 mgo f
5meC antibody pull-down DNA samples to NimbleGen Systems
for differential labelling by random priming with Cy3 or Cy5 and
hybridization to the mouse promoter arrays. Dye-swapping was
done for one replicate of every tissue type to reduce signal error
due to dye bias. Initial data preparation was performed using
the in-house developed software ChIPMonk (http://www.
bioinformatics.bbsrc.ac.uk/projects /chipmonk/). The raw array
data were subjected to a Lowess normalisation.
Pairwise Correlation and GO Analysis Protocol
The data used were the subtracted average log2 ratios from two
tissues for the 900 bp upstream of genes on autosomal
chromosomes. CpG content for a region is calculated as the
proportion of the region +/-300bp which comprises CG
dinucleotides. Only promoters with a CpG content of 2-9% and
which contained at least 5 probes were used for these analyses.
Firstly, for the correlation analysis, R-values were compared for
significant correlation both within and between groups. Secondly,
for the GO analysis, all GO categories of level $2 were tested. A
dataset of subtracted log2 ratios for each gene in the category was
constructed and this was tested for significant deviation from a
mean of 0 using a 2-tailed t-test. T-test p-values were adjusted
using Bonferoni multiple testing correction. Interesting categories
were judged to be those with a corrected p-value of ,0.01. Where
multiple nested categories were present only the most specific
category (the one with the highest GO level) was kept.
Promoter Methylation Prediction from meDIP Data
Only promoters with a CpG content of 2–9% and which
contained at least 5 probes were used, it is therefore likely that
genome-representation has not been reached in this study. For the
algorithm we set limits on the Log2 values to define regions we
considered to be methylated and unmethylated. Regions were
selected by using a 500 bp sliding window to identify areas where
the methylation state consistently and significantly changed
between the two tissues being compared.
Promoter Methylation Analysis using Sequenom
Technology
Genomic DNA from R1-ES, pMEF (passages 1 and 5), TS cells
and sperm were bisulphite treated using the Zymo EZ DNA
methylation kit (Zymo research). Candidates were selected
randomly for the TS vs. ES cell comparison, and by a
predominantly hierarchical approach based on the predicted
methylation status in pMEFs for the pMEF vs ES cell comparison.
Promoter regions were selected based on the position of the
oligonucleotides on the NimbleGen promoter array and primer
pairs were designed using the MethPrimer program (http://www.
urogene.org/methprimer/index1.html). A complete list of primers
used for analysis is available on request. Amplification of the
bisulphite converted DNA, preparation of PCR products for
quantitative analysis of promoter methylation detected by the
Mass Array system was according to the protocol provided by the
manufacturer. An example of methylation analysis using this
method is shown (Figure S1).
Quantitative RT-PCR
Total RNA was purified from 3 cell types, R1-ES, pMEFs
(passages 1) and TS cells, using the RNeasy kit (QIAGEN) to
eliminate contaminating genomic DNA; this was followed by
DNase treatment of eluted RNA. cDNA was synthesized using
SuperScript II reverse transcriptase and Oligo (dT) primers
(Invitrogen) in a 20 ml reaction volume according to the
manufacturer’s protocol. For the PCR reactions we used Platinum
SYBR Green qPCR SuperMix-UDG with ROX (Invitrogen)
using the MX3005P machine (Stratagene). Reactions were done in
triplicate using 1 ml of cDNA as a template in a 25 ml reaction
volume. The amount of starting cDNA was normalized to three
reference genes (Dynein, Rsp23 and Hdac10-11 in ES vs pMEFs;
Dynein, Pmm1 and Sdha in ES vs TS). The selected reference genes
were the most consistently expressed of 12 tested references genes
within the comparing cell types.
Comparison with Other ChIP Datasets
The meDIP datasets (ES cells versus pMEFs and ES cells versus
TS cells) used were under the same filtering criteria as for the GO
analysis. Methylation comparisons were done using gene subsets
taken from published ChIP datasets of Nanog/Oct4-binding sites
[43], or PcG protein-binding sites [45], or histone H3K4/H3K27
methylation [48]. A dataset of subtracted log2 ratios for each gene
in the ChIP dataset was constructed and this was tested for
significant deviation from a mean of 0 using a 2-tailed t-test. T-test
p-values were adjusted using Bonferoni multiple testing correction.
A p-value of ,0.01 was taken to indicate an overall shift in the
methylation state in the subset of genes.
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PMEF feeder cells were seeded at 5610
5 cells/well in six-well
tissue culture plates coated with gelatin and incubated for 24 h.
The growth medium was removed and R1 ES (5610
5) cells were
plated in ES medium with LIF one day before transfection.
Plasmids for co-transfection, including Gal4-Dnmt3a WT and
Mut (6 mg/well), pdsRed2-C1 (1 mg/well), Nanog promoter GFP
reporter plasmids including LR/Nanog-GFP, 3xUAS-NanogGFP
and 6xUAS-NanogGFP (1 mg/well) were diluted with Opti-MEM
I Reduced Serum Medium without serum. Transfection was
carried out using Lipofectamine 2000 (Invitrogen) according to the
manufacturer’s protocol. Samples were analysed 2 days after
transfection.
Bisulphite PCR Amplification
Primers were designed to specifically amplify the bisulphite-
converted DNA region of interest. Nested PCR was performed
with PCR conditions: 94uC for 2 min followed by 10 cycles
consisting of 94uC for 30 s, 50–55uC for 2 min, 72uC for 2 min,
20 cycles consisting of 94uC for 30 s, 50–55uC for 1.5 min, 72uC
for 2 min plus 5 extra s for each cycle, with a final 72uC extension
for 5 minutes. Primers used for nested PCR were: Nanog
promoter F 59-AATAGAGATT TTGGTAGTAAGGTTTG, R
59-ACCCACACTCATATCAATATAATAAC; Nanog promoter
nested F 59-TTAGGGTTTGGAGGTGTAGT, R 59-CCCA-
CACTCATATCAATATAATAAC; Nanog-GFP F 59-AAATA-
GAGATTTTGGTAGTAAGGTTT, R 59-ACAAATAAACTT-
CAAAA TCAACTTA; Nanog-GFP nested F 59-TAGAAAGAA-
TGGAAGAGGAAATTTAG, R 59-AATA ATAAAACAACA-
CAATAACCAAC. Lefty1 nested PCR primers and conditions are
available on request. 1–3 ml of the first PCR product was used for
setting up the second nested PCR reaction.
Microarray Database
ArrayExpress accession number E-TABM-476 provides access to
our MIAME-compliant data http://www.ebi.ac.uk/microarray-
as/aer/.
Supporting Information
Figure S1 Validation of meDIP candidate, Lefty1, by bisulphite
sequencing and Sequenom MassArray technology. The ChIP-
Monk profile of the promoter region of Lefty1 in ES and TS cells is
shown in the top panel. The middle line represents the median
signal intensity of the array. Each vertical bar represents the
methylation signal at an individual oligonucleotide probe; above
the median line indicates relative hypermethylation and below
indicates relative hypomethylation. Bisulphite sequencing analysis
of the promoter of Lefty1 showed that it is highly methylated in TS
cells but not in ES cells, which is in agreement with the meDIP
ChIPMonk pattern above. CpG dinucleotides are represented as
open circles (unmethylated) or closed circles (methylated). The
percentage of CpG methylation is indicated in brackets. A
Sequenom profile of the promoter is shown in the middle panel.
Sequenom MassArray technology gives quantitative measure-
ments of the methylation level and is comparable to the classical
bisulphite sequencing analysis. Blue circles indicate complete
methylation; yellow circles indicate no methylation at individual
CpG units. Examples of the MassArray spectra of a differentially
methylated CpG unit upon which this colour coding is based are
shown in the bottom panel. Methylation level is measured by the
area ratio of methylation peak to non-methylation peak. The
number of differentially methylated CpGs was counted and the
average methylation level across those CpGs in each cell type
plotted in Figure 3A.
Found at: doi:10.1371/journal.pgen.1000116.s001 (2.16 MB TIF)
Table S1 Summary of the genes analysed and the different filters
which removed them.
Found at: doi:10.1371/journal.pgen.1000116.s002 (0.03 MB
DOC)
Table S2 Gene list of ES cell versus pMEFs comparison.
Found at: doi:10.1371/journal.pgen.1000116.s003 (0.03 MB
XLS)
Table S3 Gene list of ES cell versus TS cell comparison.
Found at: doi:10.1371/journal.pgen.1000116.s004 (0.03 MB
XLS)
Table S4 Gene list of overlapping genes between ES cell versus
pMEFs and ES cell versus TS cell comparisons.
Found at: doi:10.1371/journal.pgen.1000116.s005 (0.02 MB
XLS)
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